Estimating Patient Time Costs Associated With Colorectal Cancer Care
Bibliographic Data
| ID | 9104992 |
|---|---|
| Authors | K Robin Yabroff (0000-0003-0644-5572, National Cancer Institute, corresponding author), Joan L Warren (0000-0002-6467-6769, National Cancer Institute, corresponding author), Kevin Knopf (0000-0002-5747-6128), William W Davis (0000-0001-7062-9531), Martin L Brown (National Cancer Institute, corresponding author) |
| Year | 2005 |
| Volume | 43 |
| Issue | 7 |
| Pages | 640-648 |
| Publication date | 2005-07-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | Medical Care (JOURNAL) |
| Journal identifiers | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Publisher | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/01.mlr.0000167177.45020.4a |
| PMID | 15970778 |
| OpenAlex | W1973683893 |
| Language | EN |
| Citations received | 9 |
| References cited | 25 |
BACKGROUND: Nonmedical costs of care, such as patient time associated with travel to, waiting for, and seeking medical care, are rarely measured systematically with population-based data. OBJECTIVES: The purpose of this study was to estimate patient time costs associated with colorectal cancer care. METHODS: We identified categories of key medical services for colorectal cancer care and then estimated patient time associated with each service category using data from national surveys. To estimate average service frequencies for each service category, we used a nested case control design and SEER-Medicare data. Estimates were calculated by phase of care for cases and controls, using data from 1995 to 1998. Average service frequencies were then combined with estimates of patient time for each category of service, and the value of patient time assigned. Net patient time costs were calculated for each service category, summarized by phase of care, and compared with previously reported net direct costs of colorectal cancer care. RESULTS: Net patient time costs for the 3 phases of colorectal cancer care averaged dollar 4592 (95% confidence interval [CI] dollar 4427-4757) over the 12 months of the initial phase, dollar 2788 (95% CI dollar 2614-2963) over the 12 months of the terminal phase, and dollar 25 (95% CI: dollar 23-26) per month in the continuing phase of care. Hospitalizations accounted for more than two thirds of these estimates. Patient time costs were 19.3% of direct medical costs in the initial phase, 15.8% in the continuing phase, and 36.8% in the terminal phase of care. CONCLUSIONS: Patient time costs are an important component of the costs of colorectal cancer care. Application of this method to other tumor sites and inclusion of other components of the costs of medical care will be important in delineating the economic burden of cancer in the United States
Cancer · Colorectal cancer · Confidence interval · Environmental health · Family medicine · Population · Service (business) · Economic and Financial Impacts of Cancer · Global Cancer Incidence and Screening · Healthcare Operations and Scheduling Optimization · Internal Medicine · Medicine
Annual Patient Time Costs Associated With Medical Care Among Cancer Survivors in the United States
Time spent on health related activities associated with chronic illness
Comparing VA and Private Sector Healthcare Costs for End-stage Renal Disease
Cost Comparisons and Methodological Heterogeneity in Cost-of-illness Studies
Revisiting the Cost-Effectiveness of the Combine Study for Alcohol Dependent Patients
Time is Money for Both the Healthy and the Sick
Trends in Treatment Costs for Localized Prostate Cancer
Health-Related Activities in the American Time Use Survey
A Composite Measure of Personal Financial Burden Among Patients With Stage III Colorectal Cancer
Cost-Effectiveness in Health and Medicine
Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees
Access to Medical Care and the Local Supply of Physicians
Obtaining Long-Term Disease Specific Costs of Care
Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis
Utility of the Seer-Medicare Data to Identify Chemotherapy Use
Travel for Ambulatory Medical Care
Studying Radiation Therapy Using Seer-Medicare-Linked Data
| Unique citing works | 9 |
|---|---|
| Citations per year | 0,43 |
| Citation span | 2005 - 2014 (10) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 8 |